The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1297-1301 , October 2004

THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?

REFERENCES 

  1. Stamey TA , Yang N , Hay AR , McNeal JE , Freiha FS , Redwine E . Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate . N Engl J Med . 1987;317:909
  2. Stamey TA , Kabalin JN , McNeal JE , Johnstone IM , Freiha F , Redwine EA , et al.   Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients . J Urol . 1989;141:1076
  3. Stamey TA . Preoperative serum prostate-specific antigen (PSA) below 10 microg/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure . Clin Chem . 2001;47:631
  4. Stamey TA , Johnstone IM , McNeal JE , Lu AY , Yemoto CM . Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml . J Urol . 2002;167:103
  5. Stamey TA , McNeal JE , Yemoto CM , Sigal BM , Johnstone IM . Biological determinants of cancer progression in men with prostate cancer . JAMA . 1999;281:1395
  6. Noguchi M , Stamey TA , McNeal JE , Yemoto CM . Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers . J Urol . 2000;164:1596
  7. Orozco R , Kunnel B , O'Dowd GJ , Stamey TA . Positive prostate biopsy rate consistently increases with age at the same prostate-specific antigen level in patients with normal digital rectal examination . Urology . 1998;51:531
  8. Veltri RW , Miller MC , O'Dowd GJ , Partin AW . Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer . Urology . 2002;60(suppl.):47
  9. Noldus J , Stamey TA . Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volume as measured by correlation coefficients . J Urol . 1996;155:232
  10. McNeal JE , Haillot O . Patterns of spread of adenocarcinoma in the prostate as related to cancer volume . Prostate . 2001;49:48
  11. Noguchi M , Stamey TA , McNeal JEMc , Yemoto CEM . An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics . J Urol . 2000;163:1751
  12. Hodge KK , McNeal JE , Terris MK , Stamey TA . Random systematic versus directed ultrasound-guided transrectal core-biopsies of the prostate . J Urol . 1989;142:71
  13. Presti JC , O'Dowd GJ , Miller MC , Mattu R , Veltri RW . Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study . J Urol . 2003;169:125
  14. Stewart CS , Leibovich BC , Weaver AL , Lieber MM . Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies . J Urol . 2001;166:86
  15. Ries LAG , Eisner MP , Kosary CL , Hankey BF , Miller BA , Clegg L , et al.   SEER Cancer Statistics Review, 1975–2000 . Bethesda: National Cancer Institute; 2003; http://seer.cancer.gov/csr/1975_2000
  16. Sakr WA , Grignon DJ , Haas GP , Heilbrun LK , Pontes JE , Crissman JD . Age and racial distribution of prostatic intraepithelial neoplasia . Eur Urol . 1996;30:138
  17. Rich AR . On the frequency of occurrence of occult carcinoma of the prostate . J Urol . 1935;33:215
  18. McNaughton Collins M , Ransohoff DF , Barry MJ . Early detection of prostate cancer. Serendipity strikes again . JAMA . 1997;278:1516
  19. Punglia RS , D'Amico AV , Catalona WJ , Roehl KA , Kuntz KM . Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen . N Engl J Med . 2003;349:335
  20. Roehrborn CG , McConnell J , Bonilla J , Rosenblatt S , Hudson PB , Malek GH , et al.   Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia . J Urol . 2000;163:13

 Accepted for publication April 8, 2004.

PII: S0022-5347(05)61155-X

doi: 10.1097/01.ju.0000139993.51181.5d

The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1297-1301 , October 2004

Article Tools

* Image Usage & Resolution